跳转至内容
Merck
CN

267252

Sigma-Aldrich

foil, thickness 0.1 mm, 99.99% trace metals basis

别名:

Platinum element, Platinum gray

登录查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
Pt
化学文摘社编号:
分子量:
195.08
EC 号:
MDL编号:
UNSPSC代码:
12352300
PubChem化学物质编号:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

方案

99.99% trace metals basis

表单

foil

电阻率

10.6 μΩ-cm, 20°C

厚度

0.1 mm

沸点

3827 °C (lit.)

mp

1772 °C (lit.)

密度

21.45 g/cm3 (lit.)

SMILES字符串

[Pt]

InChI

1S/Pt

InChI key

BASFCYQUMIYNBI-UHFFFAOYSA-N

一般描述

Platinum foils may be used to fabricate multi-electrode spiral nerve cuffs. It was found to be the most active catalyst in the kinetic study of catalytic oxidation of alkanes over platinum foils.

制备说明

1.3g=25×25mm;5.3g =50×50mm

储存分类代码

13 - Non Combustible Solids

WGK

nwg

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Structure characterization of platinum foil for neural stimulating electrodes
Peclin P, et al.
Bio-medical materials and engineering, 24, 1827-1835 (2014)
Kinetic study of the catalytic oxidation of alkanes over nickel, palladiium and platinum foils
Aryafar M and Zaera F
Catalysis Letters, 48, 173-183 (1997)
Yao-Hsuan Tseng et al.
Biochimica et biophysica acta, 1830(6), 3787-3795 (2013-04-02)
Traditional antibacterial photocatalysts are primarily induced by ultraviolet light to elicit antibacterial reactive oxygen species. New generation visible-light responsive photocatalysts were discovered, offering greater opportunity to use photocatalysts as disinfectants in our living environment. Recently, we found that visible-light responsive
Shanshan Cui et al.
BMC structural biology, 13, 4-4 (2013-03-23)
To explore novel platinum-based anticancer agents that are distinct from the structure and interaction mode of the traditional cisplatin by forming the bifunctional intrastrand 1,2 GpG adduct, the monofunctional platinum+DNA adducts with extensive non-covalent interactions had been studied. It was
Hiroaki Akamatsu et al.
Japanese journal of clinical oncology, 43(6), 664-668 (2013-04-16)
Interstitial lung disease associated with gefitinib is a critical adverse reaction. When geftinib was administered to EGFR-unknown patients, the interstitial lung disease incidence rate was approximately 3-4% in Japan, and usually occurs during the first 4 weeks of treatment. However

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持